Home
About
Overview
Sharing Data
ORCID
Help
History (151)
Avena
Second messenger control of chromatin remodeling.
Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis.
Postprandial Period
Is it time to abandon youth access programmes?
See All 151 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Is it time to abandon youth access programmes?
DiFranza JR. Is it time to abandon youth access programmes? Tob Control. 2002 Sep; 11(3):282; author reply 283-4.
View in:
PubMed
subject areas
Adolescent
Bias
Child
Commerce
Female
Health Education
Humans
Male
Meta-Analysis as Topic
Politics
Smoking
Smoking Prevention
United States
authors with profiles
Joseph R DiFranza MD